I am stepping out for lung cancer at the 2025 GO2 Philadelphia 5k Walk/Run. Every dollar I raise will advance GO2 for Lung Cancer’s mission to transform survival and you can help! Join me for the event or donate to help me reach my goal!
Fox Chase Cancer Center has once again been recognized among the nation’s leading institutions for cancer care in the 2025–2026 U.S. News & World Report…
‘Prime Time’ as patient: former NFL star, college football coach talks about his bladder tumor
Daniel Geynisman discusses the RETAIN-1 trial, exploring bladder preservation strategies in muscle-invasive bladder cancer. He presents results from their phase II study examining risk-enabled therapy…
At Fox Chase Cancer Center, a team-based approach ensures life-saving breast cancer treatment while safeguarding heart health
A new method of assessing workloads for clinical researchers at Fox Chase Cancer Center has proven effective in mitigating workload imbalances and improving phase 1…
Dr. Stephanie Greco, an oncologist at the Fox Chase Cancer Center, joins ‘Fox & Friends First’ to discuss the uptick in appendix cancer diagnoses and…
Using a novel method to analyze tumor growth rates, researchers at Fox Chase Cancer Center have provided the most in-depth assessment to date of how…
Zachary Klaassen discusses indeterminate renal mass management with Alexander Kutikov. Dr. Kutikov emphasizes that essentially every renal mass is indeterminate, with 20% of enhancing solid…
HIPEC is an often overlooked form of chemotherapy, with a long track record. It’s improving survival rates in some abdominal cancers, however, some patients and…
